Evidence map›Paper›PMID 35359497›Full record

ArticleRSC chemical biology2022

The identification and characterization of an oxalyl-CoA synthetase from grass pea (

Moshe Goldsmith, Shiri Barad, Yoav Peleg, Shira Albeck, Orly Dym, Alexander Brandis, Tevie Mehlman, Ziv Reich

Open access · goldAbstract read
In one paragraph

Article in RSC chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Moshe GoldsmithDept. of Biomolecular Sciences, Weizmann Institute of Science Rehovot 7610001 Israel moshe.goldsmith@weizmann.ac.il ziv.reich@weizmann.ac.il +972-8-9344118 +972-8-9343278 +972-8-9342982.ORCID https://orcid.org/0000-0002-4257-0509
Shiri BaradDept. of Biomolecular Sciences, Weizmann Institute of Science Rehovot 7610001 Israel moshe.goldsmith@weizmann.ac.il ziv.reich@weizmann.ac.il +972-8-9344118 +972-8-9343278 +972-8-9342982.
Yoav PelegDept. of Life Science Core Facilities, Weizmann Institute of Science Rehovot 7610001 Israel.
Shira AlbeckDept. of Life Science Core Facilities, Weizmann Institute of Science Rehovot 7610001 Israel.
Orly DymDept. of Life Science Core Facilities, Weizmann Institute of Science Rehovot 7610001 Israel.
Alexander BrandisDept. of Life Science Core Facilities, Weizmann Institute of Science Rehovot 7610001 Israel.
Tevie MehlmanDept. of Life Science Core Facilities, Weizmann Institute of Science Rehovot 7610001 Israel.
Ziv ReichDept. of Biomolecular Sciences, Weizmann Institute of Science Rehovot 7610001 Israel moshe.goldsmith@weizmann.ac.il ziv.reich@weizmann.ac.il +972-8-9344118 +972-8-9343278 +972-8-9342982.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxalic acid is a small metabolite found in many plants. It serves as protection from herbivores, a chelator of metal ions, a regulator of calcium levels, and additional tasks. However, it is also a strong di-carboxylic acid that can compromise plant viability by reducing cellular pH. Several metabolic pathways have evolved to control oxalate levels in plants by enzymatic degradation. Among them is the pathway that utilizes oxalyl-CoA synthetase (OCS, EC 6.2.1.8) and ATP to convert oxalate to oxalyl-CoA. Oxalyl-CoA can then be degraded to CO

Identifiers

PMID35359497
PMCPMC8905533
OpenAlexW4210914833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.